AMUNIX
Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics. The company is focused on developing prodrugs to bring the promise of potent immune-activating biotherapeutics to patients with solid tumor cancers. By delivering breakthrough therapies that can safely harness the immune system, it aims to conquer cancer and save lives. Its pipeline products are based on its proprietary XTEN half-life extension, XDC drug-conjugate d... elivery, and ProTIA pro-drug, bispecific T cell engager platform and have ongoing collaborations with biopharma corporations harnessing these delivery technologies over a wide range of therapeutic areas, delivering improved pharmaceutical technologies. Amunix was founded in 2006 and is headquartered in Mountain View, California.
AMUNIX
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2006-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.amunix.com
Total Employee:
51+
Status:
Active
Contact:
650-428-1800
Email Addresses:
[email protected]
Total Funding:
190 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
Ambys Medicines
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Gossamer Bio
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Amunix
Clough Capital Partners
Clough Capital Partners investment in Series B - Amunix
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series B - Amunix
Polaris Partners
Polaris Partners investment in Series B - Amunix
Franklin Templeton Investments
Franklin Templeton Investments investment in Series B - Amunix
CaaS Capital Management
CaaS Capital Management investment in Series B - Amunix
BlackRock
BlackRock investment in Series B - Amunix
ArrowMark Partners
ArrowMark Partners investment in Series B - Amunix
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Amunix
Longitude Capital
Longitude Capital investment in Series B - Amunix
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2013-10-08 | Versartis | Amunix investment in Series D - Versartis | 20 M USD |
Official Site Inspections
http://www.amunix.com Semrush global rank: 3.25 M Semrush visits lastest month: 5.1 K
Unable to get host informations!!!
